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The proposed use of methanol as an auto-
motive fuel and its introduction as a possi-
ble air pollutant has renewed interest in its
toxicology (1), as little is known about
either the effects of low-dose methanol
exposure or biological markers ofits toxici-
ty (2). Methanol levels in urine have been
shown to correlate with methanol exposure
(3-6). However, because methanol toxicity
is due to formate, its principal metabolite,
(7-9), formate might be a better indicator
of toxicity. Some investigators have report-
ed serum and/or urine formate concentra-
tions as biological indicators of methanol
exposure (10), although other studies have
failed to confirm this (2,4,11). In this
report, we describe the effect of 4-hr con-
stant exposure to methanol vapors at the
U.S. National Institute of Occupational
Safety and Health permissible exposure
limit of 200 ppm on serum and urine for-
mate levels in humans at rest. Data present-
ed here are part of a larger study in which
neuropsychological and visual performances
and methanol in serum and urine are mea-
sured before and after methanol exposure.
Methanol and neuropsychological data will
be presented in a subsequent work.
Of 32 subjects answering an advertise-
ment describing the study, 28 met the
inclusion criteria. After the interview and
the physical exam, one subject was excluded
because ofa history ofhepatitis B. All sub-
jects gave informed consent, and the study
was approved by the Committee on Hu-
man Research at the University of Cal-
ifornia San Francisco.
Inclusion criteria were age between 20
and 55 years, in general good health, and a
normal level offolic acid. Exclusion criteria
were a positive history of hepatitis or liver
disease, central nervous system diseases, and
drug or alcohol abuse. A questionnaire was
administered for data on medical history,
personal habits (smoking, coffee and alco-
hol consumption), occupational history,
and chemical exposure. None of the sub-
jects had known recent occupational expo-
sures to methanol, formic acid, or for-
maldehyde. Subjects were requested to fol-
low a diet from 24 hr before the experimen-
tal session and for the 8-hr duration ofthe
study. They were requested to avoid sweet-
ners and soft drinks containing aspartame
(Nutra-Sweet), vegetables, fruits, fruit juice,
roasted coffee, and alcoholic beverages in
order to reduce dietary intake ofaspartame,
methanol, and formate. Fluid intake was
not restricted with the exception of bever-
ages specified in the diet.
The exposure took place in a 2.45 x
2.45 x 2.38 m stainless-steel exposure
chamber. The chamber had a total volume
of 14.3 m3 and a ventilation rate of 11.8 air
changes/hr (2.8 m3/min). Air entering the
chamber was filtered through a charcoal fil-
ter. Temperature was maintained at 20'C
and relative humidity was 40% (12). The
vapor-generating system, located inside the
chamber, generated vapors at a rate of
43.68 g/hr. An HPLC pump delivered
either high-grade purity methanol or water
from a small reservoir onto a hot plate
(700C) to generate vapors. An oscillating
fan behind the hot plate distributed the
vapors throughout the chamber. Air sam-
ples collected at various zones inside the
chamber (corners, ceiling, floor) and at sub-
jects' breathing zone showed that methanol
vapors were uniformly distributed. An
infrared spectrometer (Miran 1B, Foxboro
Instruments, South Norwalk, Connect-
icut), placed in the middle of the chamber
was calibrated to measure methanol con-
centrations at a wavelength of 9.53 jim.
The pump delivery rate was controlled by a
personal computer that received feedback of
methanol concentrations from the spec-
trophotometer every 30 sec. We calibrated
the infrared spectrometer several times over
the course ofthe study by a closed-loop cal-
ibration method. Calibration was per-
formed between experimental exposures.
Samples from the inhalation atmosphere,
collected inside the chamber byTedlar Bag,
and calibrators for the spectrophotometer
were also determined independently by gas
chromatography (y = 0.18426 + 0.93560x,
2 r = 1.000, range: 25-225 ppm). A concen-
tration of200 ppm ofmethanol inside the
chamber was achieved before subjects
entered the chamber, and it remained stable
within the desired range (180-220 ppm)
for the full 4-hr exposure time. Analysis of
five subjects in pilot exposures, at 200 ppm
for 4 hr, showed that serum methanol con-
centrations increased from a mean of 1.29
± 0.68 mg/I at 0 hr to a mean of6.80 ± 1.6
mg/I at the end ofexposure (4 hr). This is
close to predicted concentrations based on
58% pulmonary retention, avolume ofdis-
tribution of0.6 I/kg, and a ventilation rate
at rest ofabout 10 1/min.
Subjects were exposed twice, once to
200 ppm of methanol vapors (experimen-
tal exposure) and once to water vapor
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(control exposure). The exposure condi-
tions were randomized and double blind-
ed. Only the industrial hygienist, in charge
ofthe methanol delivery system, was aware
of the presence of methanol in the cham-
ber. Volunteers were exposed in groups of
three. The methanol concentration inside
the chamber was stabilized to 200 ppm
before subjects entered and was onlyslight-
ly affected (within 10% variation) by the
door being opened. Subjects were sitting at
rest inside the chamber during the full 4-hr
exposure. Urine samples were collected
before subjects entered the chamber (0 hr),
upon exiting the chamber (4 hr) and 4 hr
later (8 hr). Blood samples were collected
by sampling from a heparin lock placed in
an antecubital vein before subjects entered
the chamber, every 15 min for the first
hour, every 30 min for 3 more hr, and
every hour for the final 4 hr. All the experi-
mental sessions were held from 0900 to
1700 hr.
We analyzed serum samples for for-
mate using an enzymatic method with a
colorimetric endpoint (13). The sensitivity
of the method is 0.5 mg/!, and the coeffi-
cient ofvariation at 12 mg/l is 10%. The
same method was used for the urine assay
by modifying the size ofthe sample (80 fil
for serum and 200 pJI for urine)
Data were analyzed using the SAS sys-
tem and included analysis of variance,
paired Student's t-test, regression, and
analysis of covariance with sex, folic acid
level, smoking habit, and age used as
covariates.
Twenty-six of the 27 enrolled subjects
completed the study, 11 females and 15
males (1 subject declined to continue the
study because of blood drawing intoler-
ance). Age was 35.8 years ± 6.9, (mean ±
SD throughout). Serum folate levels
ranged from 3.80 to 25.20 ng/ml (normal
value: above 3.1); the mean was 10.25
ng/ml. Seven were smokers (27%). No
subject was taking prescribed medications.
Two subjects were consuming multivita-
min preparations. Data on the urine con-
centration ofone subject taking more than
10 g of ascorbic acid daily were excluded
because of an interference by this amount
ofascorbic acid on the format assay.
Serum formate concentrations, at any
ofthe time points, did not show any statis-
tically significant differences between the
two exposure conditions. For example
(Table 1), the mean serum formate con-
centration at 1 hr was 10.82 ± 5.30 mg/!
during methanol exposure and 11.95 ±
6.52 mg/! during control exposure (p =
0.15). At the 4 hr time point, the mean
serum formate concentrations were higher
during methanol exposure than during
control exposure (14.28 ± 8.90 versus
12.68 ± 6.43 mg/l), although not signifi-
cantly so (p = 0.38). Also, when we com-
pared control and methanol exposure con-
ditions by computing area under the curve
(AUC) or by subtracting formate concen-
tration in serum at 0 hr, (i.e., subtracting
the endogenous serum formate or baseline)
from the serum concentration at signifi-
cant timepoints, no significant differences
were observed (Table 2) between the two
conditions.
Small changes in serum formate over
time have been observed in the sham con-
dition; both serum formate at 4 hr and
serum formate at 8 hr were higher than the
preexposure level (p < 0.05). However, the
paired changes for serum formate (either
0-4 or 0-8 hr) when compared between
exposures were not significantly different.
When analyzed by sex, serum formate
concentrations during methanol exposure
at 0, 4, and 8 hr were 10.44 ± 8.49 mg/I,
13.36 ± 8.37 mg!1, and 12.88 ± 9.07 mg/1
for females (n = 11) and 11.8 1 ± 8.00
mg/I, 14.96 ± 9.49 mg/I, and 12.00 ± 4.12
Table 1. Selected time pointsfor serum formate concentration under exposure and control conditions
Time Exposed Control
(hr) (mg/I) (mg/I) pb
0 11.23±8.07 10.33±5.51 0.45
1 10.82 ± 5.30 11.95 ± 6.52 0.15
4 14.28 ± 8.90 12.68 ± 6.43 0.38
8 12.38 ± 6.53 12.95 ± 8.01 0.60
4 minus baseline 3.0 ± 8.39 2.35 ± 3.50 0.71
aValues are expressed as means ± SD (n =26).
bp-value for atwo-tailed hypothesis.
CBaseline is value of serum formate before the exposure (0hr).
Table 2. Area underthe curve (AUC) for serum formate under exposure and control conditionsa
AUCtime Exposed Control
(hr) (mg/ml/hr) (mg/ml/hr) p
0-4 64.47 ± 31.88 61.49 ± 28.24 0.52
0-6 89.27 ± 44.30 88.89 ± 40.71 0.97
aValues are expressed as means ± SD (n =26). bprvalue for atwo-tailed hypothesis.
mg/I for males (n = 15), respectively.
During sham exposure, values were 10.27
± 7.55 mg/!, 12.63 ± 8.67 mg/!, and
12.28 ± 8.98 mg/! for females and 10.37 ±
3.68 mg/!, 12.72 ± 4.48 mg/I, and 13.45
± 7.52 mg/! for males, respectively. Anal-
ysis ofcovariance with sex used as covari-
ate was not significant.
One of the study subjects, a white
male, had an unusual response to expo-
sure. His serum formate concentrations
rose as high as 44.36 mg/I at 3.5-hr and
42.39 at 4-hr during methanol exposure
compared to a preexposure baseline con-
centration of 14.74 mg/l. During the sham
exposure, his serum formate concentration
was within the group variability. Other
subjects exposed at the same time did not
show this response. No cause for this
unusual response has been identified.
Formate excretion rate (mg/4 hr) for
both exposures are presented in Table 3.
Formate excretion at the end of the expo-
sure (0-4 hr) wasl.67 ± 1.02 mg/4 hr in
the controls (females 1.85 ± 0.83; males
1.56 ± 1.15 mg/4 hr) and for methanol
exposure was 2.17 ± 1.69 mg/4 hr (females
1.93 ± 0.89; males 2.33± 2.08 mg/4 hr);
the difference between the two exposure
conditions approached statistical signifi-
cance (p = 0.08) at the end ofthe exposure
(4 hr). Urine concentrations values are pre-
sented in Table 4. There were no statistical
differences in these comparisons or in the
changes over time.
We examined the role of other factors
as covariates by regression analysis with
various formate measures as the dependent
variable, and no significant relation was
found when sex, folic acid level, smoking
habit, and age were tested.
In this randomized, double-blind study
ofhuman exposure to methanol, in which
each subject served as his or her own con-
trol, a 4-hr exposure to a constant concen-
tration of 200 ppm methanol did not
increase serum or urine formate levels.
Methanol is readily absorbed through
the respiratory system, and inhalation is
the most common route of entry in an
occupational setting. Pulmonary retention
ofmethanol has been estimated by Sedivec
et al. (3) as being 58% ofthe inhaled dose.
In humans, alcohol dehydrogenase oxidizes
methanol to formaldehyde, and formalde-
hyde dehydrogenase oxidizes formaldehyde
to formic acid. Accumulation of formic
acid in blood occurs during acute meth-
anol intoxication, and this has been shown
in primates to be responsible for the meta-
bolic acidosis and visual toxicity, compli-
cating methanol overdose (7,14-17).
Formic acid eventually enters the one-car-
bon pool, being combined with tetrahy-
drofolate (THF) to form 10-formyl-THF,
which in turn can be directed to other
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Table 3. Urine formate excretion under exposure and control conditionsa
Time Exposed Control
(hr) (mg/4 hr) (mg/4 hr) p
0-4 2.17±1.69 1.67±1.02 0.08
4-8 1.04 ± 0.66 1.00 ± 1.08 0.87
0-8 3.21 ±2.11 2.67± 1.76 0.23
aValues are expressed as means + SD (n =25).
bp-value for atwo-tailed hypothesis.
Table 4. Formate concentration in urine under exposure and control conditions
Time Exposed Control
(hr) (mg/I) (mg/I) p
0 6.66 ± 4.97 6.29 ± 3.60 0.70
4 7.14 ± 5.17 6.64± 4.26 0.59
8 6.08 ± 3.49 5.64 ± 3.70 0.60
aValues are expressed as means ± SD (n =25).
bp-value for atwo-tailed hypothesis.
metabolic pathways or can be metabolized
to carbon dioxide and water (18,19).
Investigations have suggested that a direct
relation exists between the rate of formate
oxidation and liver content ofTHF (21).
Several studies have sought a biological
marker ofmethanol exposure. Methanol in
urine has been regarded as the most prom-
ising because it is easy to measure (19), and
it has been shown to correlate well with
blood methanol concentration (3). How-
ever, because formate is ultimately respon-
sible for methanol toxicity, it may be a bet-
ter marker from a toxicological standpoint.
Studies of formate concentrations after
methanol exposure have produced conflict-
ing results. A recent double-blind study of
human exposure to 200 ppm ofmethanol
vapors for only 75 min found no increase
in serum formate concentrations (11). As
the authors of this study suggested, a
change in formate concentration was un-
likely after 75 min of exposure. Lee et al.
(4) found no changes in serum formate
levels when comparing only two time
points (before and after a 6-hr exposure) at
200 ppm ofmethanol vapors, in a limited
sample ofsix healthy males. Baumann and
Angerer (20), in a study of 20 workers
exposed to methanol vapors in a printing
office, found a slight increase in serum for-
mate when samples from before and after
an 8-hr work shift were compared. How-
ever, this positive finding might also be
explained on the basis of dietary changes,
variability in exposure concentrations as
high as 680 ppm, cutaneous absorption
from direct contact, or increased respirato-
ry exposure due to workload. The slight
increase that these authors reported was an
isolated finding in that neither urine for-
mate concentration nor blood formate cor-
related with methanol concentration mea-
sured in the environmental air or in the
alveolar air.
Our results on urinary formate levels
support findings of some related studies
(2,4,11), namely, that exposure at the cur-
rent level of 200 ppm of methanol vapors
does not significantly increase the amount
of formic acid excreted in urine. Several
field studies have shown a slight correla-
tion between level of exposure to atmos-
pheric methanol and formate in urine. In a
field study with a control group, formate
was measured in urine collected after an 8-
hr shift at the end ofthe working week on
20 workers exposed to methanol (22).
Workers were exposed at air levels below
the permissible time-weighted average level
of 200 mg/in3 (range 37-231 mg/m3).
The slight increase that these authors
found in the exposed group was well with-
in the range ofindividual variability, there-
by precluding its use as a marker of indi-
vidual exposure. Also the subjects' diets
were not standardized. Both an unrestrict-
ed diet, by means of dietary methanol or
formate intake from foods, and also a
restricted diet, by means ofprotein catabo-
lism, could contribute to variability of
endogenous formate levels. Subjects in our
study refrained from eating foods known
to contain methanol, formate, or aspar-
tame. However, while in the chamber, they
had no food, so that at the end of the
exposure, they had fasted for 4 hr. Small
changes in serum formate were observed
during the sham exposure. Possibly the
fasting state contributed to these small
changes.
One ofour subjects showed an unusu-
allyhigh serum formate concentration dur-
ing methanol exposure but not during the
sham exposure. His urine formate excre-
tion rate was well within the group's vari-
ability. We have no explanation for this
finding, but it nevertheless seems to be an
unusual biological response that may occur
in a small portion ofthe population.
The correct time to monitor methanol
exposure has been recently debated. To test
Liesivuori and Savolainen's (10) finding of
delayed elimination of formate in urine,
Franzblau et al. (2) performed an experi-
ment in which four adult subjects were
exposed to 200 ppm of methanol in a
chamber for 6 hr. Urine formate concen-
trations were not statistically different at
the preexposure, 6-hr, and 16-hr time
points. Because this study did not have a
control group and the sample size was
small, a definitive conclusion cannot be
drawn. Yet the findings are consistent with
methanol pharmacokinetic parameters
such as half-life, volume of distribution,
and elimination rate at low concentrations
(18,21,24).
Previous studies have lacked at least
one of the following: a control group,
maintenance ofa constant or known expo-
sure, randomization, serial determination
of serum and urine formate, an exposure
period of 4 hr or more, blinding, and
dietary safeguards. Our study included
these features in its design and showed no
formate increase in serum and urine after
methanol exposure at 200 ppm.
The preexposure level for both urine
and serum formate can be regarded as a
measurement of endogenous level or base-
line. The value for urine formate that we
report in this study is within the range of
values reported by others (18), regardless
of the analytical procedure used. Serum
formate levels are in good agreement with
values reported by Lee et al. [about 10
mg/I (4)], but higher than values reported
by Cook and co-workers [3.5 mg/l (11)].
The explanation for the latter lower value
can be found, as the authors suggested, in
the subjects' strictly controlled diet, but an
analytical bias cannot be excluded.
Regression analysis demonstrated no
significant effects due to age, sex, folate
level, or smoking status. A power analysis
revealed an 80% probability that a mean
change in serum formate of 5 mg/l could
have been detected. This change is mean-
ingful in that it would be far smaller than
the amount known to cause toxicity and is
small compared to the interindividual vari-
ability. Variability in this study design
could further be reduced by standardizing
other variables including sex, height,
weight, and other dietary factors. Analytic
variability could also contribute to the
overall observed variability. However, ana-
lytical variability would represent only a
small component of intraindividual vari-
ability and intraindividual variability was
reduced by analyzing paired samples
(exposed and control) in the same batch.
While exposure to several different levels of
methanol above the threshold limit value
might demonstrate slight increases in for-
mate concentrations, it seems doubtful
that this measure would be useful for mon-
itoring individual low-level exposure.
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Volume 101, Supplement 6, contains the proceedings ofthe
Symposium on the Health Effects ofGasoline held November 5-8,
1991, in Miami, Florida. The main objective ofthe Symposium
was to determine what evidence exists for the adverse health effects
ofgasoline. Sponsors ofthe conference were the petroleum and
automotive industries, government agencies, and private research
institutions from the United States, England, Japan, and Sweden.
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